• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer.

作者信息

Denmeade S R, Isaacs J T

机构信息

Johns Hopkins Oncology Center, Johns Hopkins School of Medicine, Baltimore, MD 21231-001, USA.

出版信息

Cancer J Sci Am. 1998 May;4 Suppl 1:S15-21.

PMID:9619266
Abstract
摘要

相似文献

1
Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer.前列腺特异性抗原对前体药物的酶促激活：转移性前列腺癌的靶向治疗
Cancer J Sci Am. 1998 May;4 Suppl 1:S15-21.
2
[Role of mitoxantrone in the treatment of hormone-independent metastatic cancer of the prostate].
Prog Urol. 2002 Feb;12(1 Suppl 2):31-5.
3
In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.使用抗γ-Sm单链抗体片段/人羧酸磷酸酶A融合蛋白对前列腺癌进行体外和体内前药治疗。
Prostate. 2006 Jun 1;66(8):858-66. doi: 10.1002/pros.20402.
4
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.前列腺特异性抗原对阿霉素-肽前药的酶促激活作用。
Cancer Res. 1998 Jun 15;58(12):2537-40.
5
PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.阿霉素的PSA靶向肽缀合物向其活性代谢物的PSA特异性和非PSA特异性转化。
Drug Metab Dispos. 2001 Mar;29(3):313-8.
6
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo.
Nat Med. 2000 Nov;6(11):1248-52. doi: 10.1038/81351.
7
New strategies for the medical treatment of prostate cancer.前列腺癌医学治疗的新策略。
BJU Int. 2005 Dec;96 Suppl 2:35-40. doi: 10.1111/j.1464-410X.2005.05945.x.
8
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.原发性人类前列腺癌及人类前列腺癌异种移植模型细胞外液中具有酶活性的前列腺特异性抗原（PSA）的浓度。
Prostate. 2001 Jun 15;48(1):1-6. doi: 10.1002/pros.1075.
9
In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.一种PSA激活的阿霉素前药对产生PSA的人前列腺癌异种移植瘤的体内活性。
Prostate. 2000 Sep 15;45(1):80-3. doi: 10.1002/1097-0045(20000915)45:1<80::aid-pros10>3.0.co;2-q.
10
Prostate cancer cell survival pathways activated by bone metastasis microenvironment.由骨转移微环境激活的前列腺癌细胞存活途径。
J Musculoskelet Neuronal Interact. 2005 Jun;5(2):135-44.

引用本文的文献

1
Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy.筛选新的肽底物，用于开发可被前列腺特异性抗原（PSA）裂解的白蛋白结合抗癌前药，以提高抗肿瘤疗效。
Biochem Biophys Rep. 2021 Mar 2;26:100966. doi: 10.1016/j.bbrep.2021.100966. eCollection 2021 Jul.
2
Thapsigargin-From Traditional Medicine to Anticancer Drug.从传统药物到抗癌药物——芝麻素。
Int J Mol Sci. 2020 Dec 22;22(1):4. doi: 10.3390/ijms22010004.
3
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours.
米普司他丁，一种新型的基于毒胡萝卜素的前列腺特异性膜抗原激活前药：难治性、晚期或转移性实体瘤患者的首次人体I期临床试验结果。
Br J Cancer. 2016 Apr 26;114(9):986-94. doi: 10.1038/bjc.2016.72.
4
Optimization of an albumin-binding prodrug of Doxorubicin that is cleaved by prostate-specific antigen.一种由前列腺特异性抗原裂解的阿霉素白蛋白结合前药的优化。
ACS Med Chem Lett. 2010 May 26;1(5):234-8. doi: 10.1021/ml100060m. eCollection 2010 Aug 12.
5
The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.氟尿苷和吉西他滨的二肽单酯前药 - 口服可给予的核苷类似物的可行性。
Pharmaceuticals (Basel). 2014 Jan 27;7(2):169-91. doi: 10.3390/ph7020169.
6
Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.工程化前列腺特异性膜抗原激活的肿瘤内皮细胞前药用于癌症治疗。
Sci Transl Med. 2012 Jun 27;4(140):140ra86. doi: 10.1126/scitranslmed.3003886.
7
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.一种前列腺特异性抗原激活的通道形成毒素用于治疗前列腺疾病。
J Natl Cancer Inst. 2007 Mar 7;99(5):376-85. doi: 10.1093/jnci/djk065.
8
A history of prostate cancer treatment.前列腺癌治疗史。
Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801.